OREANDA-NEWS. Sistema JSFC ("Sistema") (LSE: SSA), the largest publicly-traded diversified holding company in Russia and the CIS, announces the appointment of Pavel Medvedev as the new Chief Executive Officer of CJSC Binnopharm ("Binnopharm") with immediate effect. Mr. Medvedev previously held the position of Deputy CEO at the company. Alexey Chupin, Chief Executive Officer of Binnopharm, resigned from his position at the company. Mr. Chupin will continue to participate in the development of the company's strategy as a member of its Board of Directors and as the company's minority shareholder.

Pavel Medvedev was born in 1967. In January 2013, Mr. Medvedev was appointed as Deputy CEO - Operations Director of Binnopharm. Prior to joining Binnopharm, between 2011 and 2012, he served as Chief Executive Officer of JSC Canonpharma Production. From 2004 to 2011, Mr. Medvedev worked at Protek Group, where he became Deputy CEO of Sotex Pharm Firm, LLC., having started out as Head of Hospitals Sales Division. Between 2000 and 2004, Mr. Medvedev was at CJSC Intermedservice Company, where he worked his way up from Manager of Commercial Department to Head of Oncology Division in the Marketing Department. From 1998 to 2000, Mr. Medvedev studied at the clinical residency and postgraduate school of the Hematological Scientific Centre at the Russian Academy of Medical Science. Upon graduation, Mr. Medvedev obtained a doctorate certificate as a hematologist. Pavel Medvedev graduated from the Military Medical Academy named after S.M. Kirov with a specialisation in medical care.